Advance Stroke and CNS Drug Development with Human-Relevant BBB Organoids
Blood–Brain Barrier (BBB) organoids are advanced three-dimensional (3D) in vitro models designed to recapitulate the structural and functional complexity of the human blood–brain barrier. These organoids are typically composed of brain microvascular endothelial cells, pericytes, astrocytes, and supporting extracellular matrix components, forming a multicellular architecture that closely mimics the in vivo BBB.
Ace Therapeutics' BBB Organoids provide a powerful in vitro platform for investigating BBB biology and evaluating novel stroke therapies in a controlled and human-relevant environment.
Download this poster to learn about:
- Modeling BBB dysfunction associated with stroke
- Assessing changes in permeability and transporter activity
- Evaluating therapeutic candidates and drug delivery strategies
- Advanced organoid characterization techniques
- Functional and molecular assays for BBB research
- Customized solutions for stroke-focused drug discovery programs
Access the poster today and explore how BBB organoids can help accelerate your stroke and CNS drug development programs.